Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.